HomeArchiveVolume 4Volume 4, issue 2Volume 4, issue 2, pp. 58-65

Montassar Ghaleb1, Hanen Bouaziz1, Sarah Sghaier1, Maher Slimane1, Hatem Bouzaiene1, Jamel Ben Hassouna1, Tarek Ben Dhiab1, Monia Hechiche1, Riadh Chargui1, Khaled Rahal1

1The surgical oncology department; Salah Azaiez Institute of Cancer; Tunis; Tunisia. The Faculty of Medicine Tunis El Manar


Ovarian cancer has the worst prognosis of all gynecologic malignancies. The standard treatment of patients with ovarian cancer is a multidisciplinary assignment involving aggressive surgery with or without chemotherapy.

Among the prognostic factors, the residual disease is of capital importance. Surgical outcomes, including the amount of residual disease, would be better if the surgical oncologist performed it. This optimal surgical treatment according to guidelines may provide the most important benefit in survival.

This current review aims at highlighting the positive relationship between complete cytoreductive surgery and survival.

Patients with OC should be referred to surgical oncologists providing high-quality comprehensive care.